However, no significant association between RSK4 isoform expression and clinical features was identified in STAD and CESC patients, suggesting the existence of additional yet undiscovered factors that act downstream of RSK4 isoform expression to impact patient survival. The gene discussed is RPS6KA6; the disease is cervical squamous cell carcinoma.